These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20400373)

  • 21. Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy.
    Mallon PW
    AIDS Rev; 2007; 9(1):3-15. PubMed ID: 17474309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
    Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L
    Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV lipodystrophy].
    Snopková S; Matýsková M; Povolná K; Polák P; Husa P
    Vnitr Lek; 2010 Dec; 56(12):1217-22. PubMed ID: 21261108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions.
    Kotler DP
    Liver Int; 2009 Mar; 29 Suppl 2():38-46. PubMed ID: 19187071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 27. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipodystrophy and metabolic disorders in anti-HIV therapy].
    Behrens GM; Stoll M; Schmidt RE
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV protease inhibitor-related lipodystrophy syndrome.
    Carr A
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S135-42. PubMed ID: 10860898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine.
    George JA; Venter WD; Van Deventer HE; Crowther NJ
    AIDS Res Hum Retroviruses; 2009 Aug; 25(8):771-81. PubMed ID: 19619010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of HIV infection: a systems-based approach.
    Chu C; Selwyn PA
    Am Fam Physician; 2011 Feb; 83(4):395-406. PubMed ID: 21322514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.
    Villarroya F; Domingo P; Giralt M
    Biochim Biophys Acta; 2010 Mar; 1801(3):392-9. PubMed ID: 19800025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients: considerations for psychosocial aspects.
    Fernandes AP; Sanches RS; Mill J; Lucy D; Palha PF; Dalri MC
    Rev Lat Am Enfermagem; 2007; 15(5):1041-5. PubMed ID: 18157460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals.
    Capeau J; Lagathu C; Ngono Ayissi K; Fève B; Béréziat V
    Ann Endocrinol (Paris); 2024 Jun; 85(3):255-258. PubMed ID: 38871510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose tissue biology and HIV-infection.
    Giralt M; Domingo P; Villarroya F
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):487-99. PubMed ID: 21663842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.